NCT06415305View on ClinicalTrials.gov

A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

April 17, 2024

Study Completion Date

January 30, 2025

Conditions

Acne Vulgaris

Interventions

DRUG

Winlevi (clascoterone) 1% cream

Dosed twice daily (BID)

Trial Locations (1)

40217

Skin Sciences, PLLC, Louisville

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT06415305 - A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne | Biotech Hunter | Biotech Hunter